SG11201803781XA - Treatment of retinal degeneration using progenitor cells - Google Patents
Treatment of retinal degeneration using progenitor cellsInfo
- Publication number
- SG11201803781XA SG11201803781XA SG11201803781XA SG11201803781XA SG11201803781XA SG 11201803781X A SG11201803781X A SG 11201803781XA SG 11201803781X A SG11201803781X A SG 11201803781XA SG 11201803781X A SG11201803781X A SG 11201803781XA SG 11201803781X A SG11201803781X A SG 11201803781XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- cells
- progenitor cells
- pennsylvania
- johnson
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 5
- 201000007737 Retinal degeneration Diseases 0.000 title abstract 3
- 230000004258 retinal degeneration Effects 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 abstract 4
- 230000002207 retinal effect Effects 0.000 abstract 2
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000006654 negative regulation of apoptotic process Effects 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 108091008695 photoreceptors Proteins 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562263463P | 2015-12-04 | 2015-12-04 | |
| PCT/US2016/064336 WO2017095991A1 (fr) | 2015-12-04 | 2016-12-01 | Traitement de la dégénérescence rétinienne à l'aide de cellules progénitrices |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201803781XA true SG11201803781XA (en) | 2018-06-28 |
Family
ID=58797699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803781XA SG11201803781XA (en) | 2015-12-04 | 2016-12-01 | Treatment of retinal degeneration using progenitor cells |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20170157179A1 (fr) |
| EP (1) | EP3384009A4 (fr) |
| JP (1) | JP2019501888A (fr) |
| KR (1) | KR20180088713A (fr) |
| CN (1) | CN108291199A (fr) |
| AR (1) | AR106913A1 (fr) |
| AU (1) | AU2016365312A1 (fr) |
| BR (1) | BR112018011278A2 (fr) |
| CA (1) | CA3007198A1 (fr) |
| MX (1) | MX2018006729A (fr) |
| PH (1) | PH12018501045A1 (fr) |
| RU (1) | RU2018122461A (fr) |
| SG (1) | SG11201803781XA (fr) |
| TW (1) | TW201729819A (fr) |
| WO (1) | WO2017095991A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| KR102224115B1 (ko) | 2020-01-10 | 2021-03-09 | 경북대학교병원 | 3차원 바이오프린팅 기술을 이용한 망막 세포 배양용 구조체 및 이의 활용 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001855A (en) * | 1998-01-02 | 1999-12-14 | Hoffman-La Roche Inc. | Thiazole derivatives |
| US20010041670A1 (en) * | 1999-12-06 | 2001-11-15 | Ronit Simantov | Thrombospondin-binding region of histidine-rich glycoprotein and method of use |
| PL207175B1 (pl) * | 2001-08-01 | 2010-11-30 | Merck Patent Gmbh | Zastosowanie inhibitorów integryny do wytwarzania kompozycji farmaceutycznych do zapobiegania i/lub terapii chorób oczu |
| US7560276B2 (en) * | 2003-06-27 | 2009-07-14 | Ethicon, Incorporated | Soft tissue repair and regeneration using postpartum-derived cells |
| US8790637B2 (en) * | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| AU2008321386B2 (en) * | 2007-11-15 | 2014-10-23 | The Feinstein Institute For Medical Research | Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using MFG-E8 |
| EP2707036A4 (fr) * | 2011-05-09 | 2015-03-18 | Allegro Pharmaceuticals Inc | Antagonistes des récepteurs d'intégrines et leurs procédés d'utilisation |
| US20150150996A1 (en) * | 2012-06-06 | 2015-06-04 | Northwestern University | Compositions and methods for antigen-specific tolerance |
| BR112017012581A2 (pt) * | 2014-12-16 | 2017-12-26 | Janssen Biotech Inc | tratamento de degeneração da retina com o uso de células progenitoras |
-
2016
- 2016-12-01 SG SG11201803781XA patent/SG11201803781XA/en unknown
- 2016-12-01 JP JP2018528794A patent/JP2019501888A/ja active Pending
- 2016-12-01 EP EP16871469.9A patent/EP3384009A4/fr not_active Withdrawn
- 2016-12-01 US US15/366,599 patent/US20170157179A1/en not_active Abandoned
- 2016-12-01 MX MX2018006729A patent/MX2018006729A/es unknown
- 2016-12-01 RU RU2018122461A patent/RU2018122461A/ru not_active Application Discontinuation
- 2016-12-01 CA CA3007198A patent/CA3007198A1/fr not_active Abandoned
- 2016-12-01 BR BR112018011278A patent/BR112018011278A2/pt not_active Application Discontinuation
- 2016-12-01 KR KR1020187018529A patent/KR20180088713A/ko unknown
- 2016-12-01 AU AU2016365312A patent/AU2016365312A1/en not_active Abandoned
- 2016-12-01 WO PCT/US2016/064336 patent/WO2017095991A1/fr active Application Filing
- 2016-12-01 CN CN201680071080.7A patent/CN108291199A/zh active Pending
- 2016-12-02 TW TW105139990A patent/TW201729819A/zh unknown
- 2016-12-05 AR ARP160103730A patent/AR106913A1/es unknown
-
2018
- 2018-05-16 PH PH12018501045A patent/PH12018501045A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018011278A2 (pt) | 2018-11-21 |
| AU2016365312A1 (en) | 2018-05-24 |
| EP3384009A1 (fr) | 2018-10-10 |
| EP3384009A4 (fr) | 2019-06-12 |
| US20170157179A1 (en) | 2017-06-08 |
| CA3007198A1 (fr) | 2017-06-08 |
| AR106913A1 (es) | 2018-02-28 |
| MX2018006729A (es) | 2018-11-09 |
| WO2017095991A1 (fr) | 2017-06-08 |
| TW201729819A (zh) | 2017-09-01 |
| RU2018122461A (ru) | 2020-01-13 |
| CN108291199A (zh) | 2018-07-17 |
| KR20180088713A (ko) | 2018-08-06 |
| JP2019501888A (ja) | 2019-01-24 |
| PH12018501045A1 (en) | 2019-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201803593QA (en) | Engineered nucleic-acid targeting nucleic acids | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201809649WA (en) | Macromolecule analysis employing nucleic acid encoding | |
| SG11201908391XA (en) | Methods for modulating an immune response | |
| SG11202000274RA (en) | Oligonucleotide compositions and methods thereof | |
| SG11201810179RA (en) | Novel crispr enzymes and systems | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201804152RA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201806398YA (en) | Optimized factor viii genes | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201908560SA (en) | Heterocyclic compounds useful as dual atx/ca inhibitors | |
| SG11201807269PA (en) | Filamentous fungal biomats, methods of their production and methods of their use | |
| SG11201804070XA (en) | Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a | |
| SG11201809700YA (en) | Gdf15 fusion proteins and uses thereof | |
| SG11201804510PA (en) | Biparatopic polypeptides antagonizing wnt signaling in tumor cells | |
| SG11201408095XA (en) | Fibroblast growth factor 21 proteins | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| CA3025288C (fr) | Compositions alcalines et neutres de nettoyage, d'aseptisation et de desinfection a faible embuage par l'utilisation de polymeres en emulsion d'eau dans l'huile a masse moleculaire elevee | |
| SG11201809751XA (en) | Egfr inhibitor compounds | |
| SG11201811554SA (en) | Antisense oligonucleotides for modulating htra1 expression | |
| SG11201803642WA (en) | Bacteria-based protein delivery | |
| SG11201809531SA (en) | BINDING MOLECULES SPECIFIC FOR FCγGAMMA RIIA AND USES THEREOF | |
| SG11201803918VA (en) | Production of steviol glycosides in recombinant hosts |